Amylin

Pain

Danish Headache Centerprotein_peptideN/AActive

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 81/ 100

Competitive context

43 Active assets in the Pain cohort.

Asset / Sponsor	Phase	Rating
NEPENTHE Bursa City Hospital	Phase 4	BBB
Tapentadol Grünenthal GmbH	Phase 4	BBB
Oxycodone The First Affiliated Hospital with Nanjing Medical University	Phase 4	BBB
FENTANYL Aga Khan University	Phase 4	BBB
Nabiximols Jazz Pharmaceuticals	Phase 3	BBB

View all 50 →

Same molecule, other indications

Amylin is also rated in:

Headache Disorders, PrimaryDormant

D

Indicative ·

30 / 100

Headache DisordersDormant

D

Indicative ·

30 / 100

nervous system disorderDormant

D

Indicative ·

30 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.